Chain of Custody in Drug and Alcohol Testing: Forms, Splits, and Review

The chain of custody in drug and alcohol testing is the documented trail that follows a specimen from the moment it leaves your body to the final lab report, recording every person who handles, tests, or transports it. Under Department of Transportation rules in 49 CFR Part 40, that trail lives on standardized forms and tamper-evident seals, and a gap anywhere in it can cancel the test outright. Private employers aren’t bound by Part 40, but most workplace programs mirror it closely because a defensible result depends on a defensible chain.

The Federal Custody and Control Form

Every DOT drug test runs on a document called the Federal Drug Testing Custody and Control Form, or CCF. The CCF ties one specimen to one person through a unique identification number and is the paper backbone of everything that follows. Before collection begins, the form must already carry the employer’s name and address, the Designated Employer Representative’s contact information, and the Medical Review Officer’s name and physical address. A generic clinic name or a post office box will not satisfy the requirement.¹

You present a photo ID before the collector proceeds. A government-issued ID like a driver’s license or an employer-issued photo badge works. Photocopies and faxes do not. If you can’t produce identification, the collector has to reach the employer’s Designated Employer Representative to verify who you are before going further. The collector prints their own name on the CCF, records the date and time, and signs a certification. You sign a separate certification that the specimen is yours and hasn’t been tampered with.¹

Sealing and Splitting the Specimen

The first physical link in the chain is the sealed bottle. Before you provide a sample, the collector prepares the room: water sources are shut off or taped, and the toilet water is dyed blue so any attempt to dilute the specimen would be obvious.² You remove outer clothing like jackets, hats, and coveralls and empty your pockets. You may keep your wallet. If the collector finds materials that appear designed to tamper with a sample, the collection shifts to a directly observed procedure or switches to oral fluid.³

You provide the specimen in private and hand the container directly to the collector, who checks the temperature to confirm it falls within the range expected for a freshly produced human specimen. If the temperature reads outside that range, the collector notes it and may order a new collection under direct observation.

The collector, not you, then pours at least 30 mL into the primary specimen bottle and at least 15 mL into a second bottle designated as the split specimen. The split exists so you can request an independent retest if the primary comes back positive. The collector caps both bottles, applies tamper-evident seals from the CCF over the caps and down the sides, and writes the collection date on each seal. You initial both seals to certify the bottles contain what you provided. If you refuse to initial, the collector notes it in the remarks and continues.⁴

Oral fluid collections use a manufacturer-provided device to gather at least 1 mL of undiluted saliva for each bottle, then follow the same sealing and initialing steps.¹ The collector handles the fluid, the donor witnesses and initials, and the seal is what tells every later handler that no one has opened the bottle since. A broken or reapplied seal at any downstream point gives the laboratory grounds to reject the specimen.

When Direct Observation Is Required

Most urine collections happen in private, but some require a same-gender observer to watch the specimen leave your body. This is not optional, and refusing observation counts as a refusal to test. Direct observation is mandatory for all return-to-duty and follow-up tests after a previous violation.⁵

An employer also has to order a directly observed collection when the MRO reports that a previous specimen was invalid without a medical explanation, when a split specimen test couldn’t be performed and the original result was cancelled, or when a negative-dilute result comes back with a creatinine level between 2 and 5 mg/dL. A collector can initiate direct observation on the spot if the specimen temperature is out of range, the specimen appears tampered with, or the donor brought suspicious materials.⁵

During observation, the observer asks you to raise your shirt above the waist and lower your clothing to confirm you aren’t wearing a prosthetic device, then watches the urine go from your body into the collection container. The observer’s name is recorded on the CCF.⁶

Lab Intake and the Internal Chain

Sealed specimens ship in secure containers to a laboratory certified by the Department of Health and Human Services under the National Laboratory Certification Program. Only HHS-certified labs may perform DOT drug testing.⁷ On arrival, intake staff inspect the external packaging and individual seals for damage, then compare specimen identification numbers against the CCF. Any mismatch or broken seal triggers rejection.

Inside the lab, an internal chain of custody picks up where the CCF left off. Each person who accesses the specimen records their involvement, and that internal record has to align with the CCF.⁸ The lab runs an immunoassay screen first. A negative screen ends the process. A positive screen goes to a confirmatory test using a more precise method, typically gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry.

Specimens that test positive have to be retained by the laboratory for at least one year so there’s time for split specimen retesting or a legal challenge.⁹

Medical Review Before the Employer Sees Anything

A positive lab result doesn’t go straight to your employer. It goes first to the Medical Review Officer, a licensed physician trained in substance abuse testing. The MRO decides whether a legitimate medical explanation accounts for the result, most often a valid prescription.

The MRO has to contact you for a verification interview before certifying any non-negative result. If neither the MRO nor the employer’s Designated Employer Representative can reach you within 10 days of receiving the lab result, the MRO may verify the test as positive without an interview. A shorter clock applies if the employer does reach you and tells you to call the MRO: you have 72 hours to make contact before the MRO proceeds without you.¹⁰ Even after verification without an interview, you have 60 days to present evidence that serious illness or other unavoidable circumstances kept you from responding, and the MRO can reopen the case.

If you claim a prescription during the interview, the MRO won’t just take your word. They have to call the pharmacy to verify legitimacy and may contact the prescribing physician. Photos of medication labels aren’t sufficient proof on their own.¹¹ If the prescription checks out and adequately explains the positive, the test is reported to the employer as negative. The employer never learns which medication you’re taking.

Requesting a Split Specimen Test

When the MRO informs you of a verified positive, adulterated, or substituted result, they also have to tell you about your right to test the split specimen. You have exactly 72 hours from that notification to make the request.¹² The MRO has to be reachable throughout that window, whether by phone or by an answering machine with a time-stamp feature.

If you request the split test, the original laboratory ships the sealed split bottle to a second HHS-certified lab, which runs its own confirmation. If the split fails to confirm the original result, the MRO cancels the test. This is one of the strongest protections built into the chain of custody: an independent lab reviewing a separately sealed portion of the same sample. The whole safeguard depends on those tamper-evident seals staying intact from the collection room to the second lab’s bench.

Fatal Flaws and Correctable Errors

Not every paperwork mistake kills a test, but certain errors are classified as fatal flaws that force automatic cancellation. If any of these problems exist, the MRO has no discretion:¹

No CCF at all.
A CCF completed but no specimen submitted with it.
Neither a printed name nor a signature from the collector on the form.
Two separate collections performed using a single CCF.
The identification number on the specimen bottle doesn’t match the number on the CCF.
The tamper-evident seal is broken or shows signs of tampering.
The primary bottle doesn’t contain enough specimen for analysis.
For oral fluid, the collection device was expired at the time of collection.

A cancelled test forces the employer to order a recollection. Other documentation problems are classified as correctable flaws and can be fixed if the responsible person supplies the missing information in writing on the same business day the problem is discovered. Correctable flaws include a missing collector signature, a missing donor signature (unless refusal to sign was noted in the remarks), a missing certifying scientist signature on a non-negative result, and use of an expired or non-federal form.¹ If the correction doesn’t happen in time, a correctable flaw becomes a cancelled test just like a fatal one.

What Happens When the Chain Breaks

The whole system exists to guarantee that the substance detected in a laboratory instrument actually came from the person named on the report. When any link fails, a seal that’s broken, a CCF with mismatched numbers, a courier who can’t account for the package’s whereabouts, the result becomes vulnerable.

Within the DOT framework, a broken chain typically surfaces as a fatal flaw that cancels the test outright. The MRO has no discretion; the regulations mandate cancellation for specific defects. In legal proceedings outside the DOT context, a broken chain doesn’t automatically exclude a test result, but it gives defense attorneys a real tool. Courts weigh whether the gap was significant enough to raise a reasonable possibility of tampering or contamination. Even when a result isn’t fully excluded, a documented break can undercut its credibility in front of a judge or jury.

If you’re the donor, engage with the chain while it’s still forming. Watch the collector seal your specimen. Initial the seals. Note the date on the CCF. If a result comes back positive and something about the collection didn’t look right, the 72-hour split-specimen window is your main lever, and it closes fast. The chain of custody is built to protect you as much as it protects the employer, but only if you use the checkpoints it gives you.

1
eCFR. 49 CFR Part 40 – Procedures for Transportation Workplace Drug and Alcohol Testing Programs
2
eCFR. 49 CFR Part 40 Subpart D – Collection Sites, Forms, Equipment and Supplies Used in DOT Urine and Oral Fluid Collections
3
eCFR. 49 CFR 40.61 – What Are the Steps in the Collection Process Before the Employee Provides a Urine Specimen
4
eCFR. 49 CFR 40.71 – How Does the Collector Prepare the Urine Specimen
5
U.S. Department of Transportation. 49 CFR Part 40 Section 40.67 – When and How Is a Directly Observed Urine Collection Conducted
6
eCFR. 49 CFR 40.67 – When and How Is a Directly Observed Urine Collection Conducted
7
eCFR. 49 CFR Part 40 Subpart F – Drug Testing Laboratories
8
eCFR. 49 CFR 40.83 – How Does the Laboratory Process Incoming Specimens
9
U.S. Department of Transportation. 49 CFR Part 40 Section 40.99 Q&A
10
U.S. Department of Transportation. 49 CFR Part 40 Section 40.133
11
U.S. Department of Transportation. Back to Basics for Medical Review Officers
12
eCFR. 49 CFR 40.153 – How Does the MRO Notify Employees of Their Right to a Test of the Split Specimen